Spina Alfio, Gagliardi Filippo, Boari Nicola, Bailo Michele, Mortini Pietro
Department of Neurosurgery and Gamma Knife Radiosurgery, I.R.C.C.S. San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
Department of Neurosurgery and Gamma Knife Radiosurgery, I.R.C.C.S. San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
World Neurosurg. 2017 Aug;104:612-618. doi: 10.1016/j.wneu.2017.04.132. Epub 2017 Apr 28.
Atypical teratoid rhabdoid tumors (ATRTs) are rare and aggressive tumors, usually affecting patients younger than 3 years of age, that are characterized by a poor prognosis. Nowadays multimodal management, including surgery, chemotherapy and radiation therapy (RT), is advocated depending on the patients' age and tumor stage, even if no consensus exists regarding the best treatment modality. Local RT seems to be the most effective treatment in prolonging progression-free and overall survival rates, although RT might not be used on younger children because of the risk of neurocognitive and endocrine sequelae. Stereotactic radiosurgery (SRS) is a valuable alternative therapeutic option to conventional RT because of the more conformal dose delivery. The aim of this study was to review the available literature on SRS in the management of ATRT.
The authors carried out a systematic review of PubMed, Web of Science, and Google Scholar for clinical reports dealing with SRS for the management of ATRT.
Nine studies describing 12 patients treated with SRS for ATRT were included in the analysis. Patient's clinical features, radiosurgical treatment characteristics, and follow-up data of the pertinent literature were reviewed critically. SRS represents a feasible and effective therapeutic option in the management of ATRT. Local control has been reported in 66.7% of cases; however, 33.3% of patients experienced poor survival because of craniospinal tumor dissemination.
SRS should be considered in the multimodal treatment of ATRT, and future studies should focus on a better definition of the role played by SRS in their management.
非典型畸胎样横纹肌样瘤(ATRT)是罕见且侵袭性强的肿瘤,通常影响3岁以下儿童,预后较差。如今,根据患者年龄和肿瘤分期,提倡采用包括手术、化疗和放疗(RT)在内的多模式治疗,尽管对于最佳治疗方式尚无共识。局部放疗似乎是延长无进展生存期和总生存率最有效的治疗方法,不过由于存在神经认知和内分泌后遗症的风险,年幼患儿可能不适用放疗。立体定向放射外科(SRS)因其剂量递送更适形,是传统放疗的一种有价值的替代治疗选择。本研究的目的是回顾关于SRS治疗ATRT的现有文献。
作者对PubMed、科学网和谷歌学术进行了系统回顾,以查找有关SRS治疗ATRT的临床报告。
分析纳入了9项描述12例接受SRS治疗ATRT患者的研究。对相关文献中患者的临床特征、放射外科治疗特点及随访数据进行了严格审查。SRS是治疗ATRT的一种可行且有效的治疗选择。据报告局部控制率为66.7%;然而,33.3%的患者因颅脊髓肿瘤播散而生存不佳。
在ATRT的多模式治疗中应考虑SRS,未来研究应聚焦于更好地明确SRS在其治疗中的作用。